|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
107.97(B) |
Last
Volume: |
3,217,222 |
Avg
Vol: |
8,418,111 |
52
Week Range: |
$48.64 - $75.67 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
312,036 |
508,687 |
1,007,678 |
2,119,191 |
Total Sell Value |
$23,117,519 |
$34,902,586 |
$61,221,104 |
$110,722,184 |
Total People Sold |
9 |
10 |
11 |
13 |
Total Sell Transactions |
14 |
27 |
44 |
79 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Phalen Michael P. |
EVP & President, MedSurg |
|
2012-02-16 |
4 |
D |
$5.97 |
$10,125 |
D/D |
(1,696) |
49,081 |
|
- |
|
Phalen Michael P. |
EVP & President, MedSurg |
|
2012-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,723 |
50,777 |
|
- |
|
Burns Brian R |
EVP - Global Quality & Reg Aff |
|
2012-02-16 |
4 |
D |
$5.97 |
$14,292 |
D/D |
(2,394) |
71,703 |
|
- |
|
Burns Brian R |
EVP - Global Quality & Reg Aff |
|
2012-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,747 |
74,097 |
|
- |
|
Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
|
2012-02-16 |
4 |
D |
$5.97 |
$55,479 |
D/D |
(9,293) |
72,581 |
|
- |
|
Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
|
2012-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
28,434 |
81,874 |
|
- |
|
Fitzgerald Joseph Michael |
SVP & President, CRM |
|
2012-02-16 |
4 |
D |
$5.97 |
$10,406 |
D/D |
(1,743) |
67,348 |
|
- |
|
Fitzgerald Joseph Michael |
SVP & President, CRM |
|
2012-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,723 |
69,091 |
|
- |
|
Capello Jeffrey D |
EVP & Chief Financial Officer |
|
2012-02-16 |
4 |
D |
$5.97 |
$40,118 |
D/D |
(6,720) |
114,087 |
|
- |
|
Capello Jeffrey D |
EVP & Chief Financial Officer |
|
2012-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,242 |
120,807 |
|
- |
|
Dawkins Keith D |
Sr. VP, Global Chief Med. Off. |
|
2012-02-16 |
4 |
D |
$5.97 |
$7,230 |
D/D |
(1,211) |
56,980 |
|
- |
|
Dawkins Keith D |
Sr. VP, Global Chief Med. Off. |
|
2012-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,373 |
58,191 |
|
- |
|
Pierce David A |
SVP and President, Endoscopy |
|
2012-02-13 |
4 |
D |
$5.94 |
$3,427 |
D/D |
(577) |
3,089 |
|
- |
|
Pierce David A |
SVP and President, Endoscopy |
|
2012-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,605 |
3,666 |
|
- |
|
Onuscheck John Michael |
SVP & President, EMEA |
|
2012-02-13 |
4 |
D |
$5.94 |
$4,116 |
D/D |
(693) |
47,978 |
|
- |
|
Onuscheck John Michael |
SVP & President, EMEA |
|
2012-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,638 |
48,671 |
|
- |
|
Kucheman William |
Chief Executive Officer |
|
2012-02-12 |
4 |
D |
$5.93 |
$7,774 |
D/D |
(1,311) |
81,712 |
|
- |
|
Kucheman William |
Chief Executive Officer |
|
2012-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,993 |
83,023 |
|
- |
|
Lance Jean Fitterer |
SVP & Chief Compliance Officer |
|
2012-02-12 |
4 |
D |
$5.93 |
$6,991 |
D/D |
(1,179) |
64,410 |
|
- |
|
Lance Jean Fitterer |
SVP & Chief Compliance Officer |
|
2012-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,194 |
65,589 |
|
- |
|
Neumann Lawrence R |
SVP and Pres, Emerging Markets |
|
2012-02-12 |
4 |
D |
$5.93 |
$6,292 |
D/D |
(1,061) |
67,434 |
|
- |
|
Neumann Lawrence R |
SVP and Pres, Emerging Markets |
|
2012-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,955 |
68,495 |
|
- |
|
Pucel Kenneth |
EVP, Global Ops & Technology |
|
2012-02-12 |
4 |
D |
$5.93 |
$10,490 |
D/D |
(1,769) |
93,747 |
|
- |
|
Pucel Kenneth |
EVP, Global Ops & Technology |
|
2012-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,792 |
95,516 |
|
- |
|
Onuscheck John Michael |
SVP & President, EMEA |
|
2012-02-12 |
4 |
D |
$5.93 |
$10,022 |
D/D |
(1,690) |
47,033 |
|
- |
|
1822 Records found
|
|
Page 22 of 73 |
|
|